
Presentación "Intermittent scheduled low-dose levosimendan infusions improve event-free survival in advanced chronic heart failure: a propensity score matching analysis" de los Drs. Nicolas Barras, Konstantinos Sotiropoulos, Julien Regamey, Pierre Vogt, Roger Hullin y Patrick Yerly.